Bennett Associates Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Bennett Associates Wealth Management's AMGN Position: Q2 2026 in Review
Bennett Associates Wealth Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,479 shares — an estimated $520K sold.
Bennett Associates Wealth Management first reported a position in AMGN in Q4 2023 and held it in 9 quarters. The position peaked at $529K in Q4 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Bennett Associates Wealth Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Bennett Associates Wealth Management sold 1,479 Amgen shares in Q2 2026, an estimated $520K.
- Bennett Associates Wealth Management first reported a position in Amgen in Q4 2023 and held it in 9 quarters.
- Bennett Associates Wealth Management's Amgen position peaked at $529K in Q4 2025.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Bennett Associates Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.